CinRx Pharma, LLC 4
4 · CinCor Pharma, Inc. · Filed Jan 13, 2022
Insider Transaction Report
Form 4
CinRx Pharma, LLC
10% Owner
Transactions
- Conversion
Common Stock
2022-01-11+1,222,530→ 3,630,103 total - Conversion
Series B Preferred Stock
2022-01-11−2,013,749→ 0 total→ Common Stock (592,279 underlying) - Conversion
Series A Preferred Stock
2022-01-11−2,142,856→ 0 total→ Common Stock (630,251 underlying)
Footnotes (1)
- [F1]Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.